Table 2.
Immunohistochemistry results with regard to p16, p53, and WT1 staining intensity in benign, low-grade, and high-grade serous ovarian tumors.
| Intensity | Benign (n = 10) |
LOSC (n = 8) |
HOSC (n = 23) |
||||||
|---|---|---|---|---|---|---|---|---|---|
| p16 | p53 | WT1 | p16 | p53 | WT1 | p16 | p53 | WT1 | |
| Negative (0) | 3 (30%) | 9 (90%) | 8 (80%) | 0 | 4 (50%) | 3 (37.5%) | 1 (4.35%) | 3 (13.04%) | 0 |
| Weak (1+) | 3 (30%) | 1 (10%) | 2 (20%) | 5 (62.5%) | 2 (25%) | 5 (62.5%) | 1 (4.35%) | 1 (4.35%) | 5 (21.74%) |
| Mod (2+) | 4 (40%) | 0 | 0 | 3 (37.5%) | 1 (12.5%) | 0 | 6 (26.09%) | 8 (34.78%) | 6 (26.1%) |
| Strong (3+) | 0 | 0 | 0 | 0 | 1 (12.5%) | 0 | 15 (65.22%) | 11 (47.83%) | 12 (52.2%) |
LOSC, low-grade ovarian serous carcinoma; HOSC, high-grade ovarian serous carcinoma; n, number of cases.